US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
US7101993B1
(en)
|
1990-01-11 |
2006-09-05 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides containing 2′-O-modified purines
|
US6268213B1
(en)
|
1992-06-03 |
2001-07-31 |
Richard Jude Samulski |
Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
US5869305A
(en)
|
1992-12-04 |
1999-02-09 |
The University Of Pittsburgh |
Recombinant viral vector system
|
JPH08506144A
(ja)
|
1993-02-05 |
1996-07-02 |
ラポート グループ オーストラリア リミティド |
スラグ脱泡複合材料
|
US20020173474A1
(en)
|
1993-02-12 |
2002-11-21 |
President And Fellows Of Harvard College |
Methods & materials involving dimerization-mediated regulation of biological events
|
US5869337A
(en)
|
1993-02-12 |
1999-02-09 |
President And Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
US5830462A
(en)
|
1993-02-12 |
1998-11-03 |
President & Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
PL310327A1
(en)
|
1993-02-12 |
1995-12-11 |
Univ Leland Stanford Junior |
Adjustable transcription of target genes and other biological processes
|
US6972193B1
(en)
|
1993-02-12 |
2005-12-06 |
Board Of Trustees Of Leland Stanford Junior University |
Regulated transcription of targeted genes and other biological events
|
US5834266A
(en)
|
1993-02-12 |
1998-11-10 |
President & Fellows Of Harvard College |
Regulated apoptosis
|
US6140120A
(en)
|
1993-02-12 |
2000-10-31 |
Board Of Trustees Of Leland Stanford Jr. University |
Regulated transcription of targeted genes and other biological events
|
US6150137A
(en)
|
1994-05-27 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Immunosuppressant target proteins
|
US6476200B1
(en)
|
1994-06-27 |
2002-11-05 |
The Johns Hopkins University |
Mammalian proteins that bind to FKBP12 in a rapamycin-dependent fashion
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
US6133456A
(en)
|
1994-08-18 |
2000-10-17 |
Ariad Gene Therapeutics, Inc. |
Synthetic multimerizing agents
|
WO1996006097A1
(en)
|
1994-08-18 |
1996-02-29 |
Ariad Gene Therapeutics, Inc. |
New multimerizing agents
|
US6150527A
(en)
|
1994-08-18 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Synthetic multimerizing agents
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
ATE544776T1
(de)
|
1994-12-29 |
2012-02-15 |
Massachusetts Inst Technology |
Chimäre dna-bindeproteine
|
US6326166B1
(en)
|
1995-12-29 |
2001-12-04 |
Massachusetts Institute Of Technology |
Chimeric DNA-binding proteins
|
US6166197A
(en)
|
1995-03-06 |
2000-12-26 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions
|
CA2219080A1
(en)
|
1995-06-07 |
1996-12-27 |
Ariad Gene Therapeutics, Inc. |
Rapamycin-based regulation of biological events
|
US5811524A
(en)
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
US6506379B1
(en)
|
1995-06-07 |
2003-01-14 |
Ariad Gene Therapeutics, Inc. |
Intramuscular delivery of recombinant AAV
|
US5741683A
(en)
|
1995-06-07 |
1998-04-21 |
The Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
US6187757B1
(en)
|
1995-06-07 |
2001-02-13 |
Ariad Pharmaceuticals, Inc. |
Regulation of biological events using novel compounds
|
US6093570A
(en)
|
1995-06-07 |
2000-07-25 |
The University Of North Carolina At Chapel Hill |
Helper virus-free AAV production
|
WO1997031898A1
(en)
|
1996-02-28 |
1997-09-04 |
Ariad Gene Therapeutics, Inc. |
Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
|
US6723531B2
(en)
|
1996-04-05 |
2004-04-20 |
The Salk Institute For Biological Studies |
Method for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
WO1998002441A2
(en)
|
1996-07-12 |
1998-01-22 |
Ariad Pharmaceuticals, Inc. |
Non immunosuppressive antifungal rapalogs
|
JP2002503954A
(ja)
|
1997-04-01 |
2002-02-05 |
グラクソ、グループ、リミテッド |
核酸増幅法
|
ES2224375T3
(es)
|
1997-04-14 |
2005-03-01 |
Cell Genesys, Inc. |
Metodos para aumentar la eficacia del producto de aav recombinante.
|
WO1999010510A2
(en)
|
1997-08-26 |
1999-03-04 |
Ariad Gene Therapeutics, Inc. |
Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
|
US6015709A
(en)
|
1997-08-26 |
2000-01-18 |
Ariad Pharmaceuticals, Inc. |
Transcriptional activators, and compositions and uses related thereto
|
US6479653B1
(en)
|
1997-08-26 |
2002-11-12 |
Ariad Gene Therapeutics, Inc. |
Compositions and method for regulation of transcription
|
AU752129B2
(en)
|
1997-08-27 |
2002-09-05 |
Ariad Gene Therapeutics, Inc. |
Chimeric transcriptional activators and compositions and uses related thereto
|
WO1999036553A2
(en)
|
1998-01-15 |
1999-07-22 |
Ariad Gene Therapeutics, Inc. |
Regulation of biological events using multimeric chimeric proteins
|
US6984635B1
(en)
|
1998-02-13 |
2006-01-10 |
Board Of Trustees Of The Leland Stanford Jr. University |
Dimerizing agents, their production and use
|
AU766513B2
(en)
|
1998-02-13 |
2003-10-16 |
Board Of Trustees Of The Leland Stanford Junior University |
Novel dimerizing agents, their production and use
|
US6333318B1
(en)
|
1998-05-14 |
2001-12-25 |
The Salk Institute For Biological Studies |
Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
EP1080218A1
(en)
|
1998-05-27 |
2001-03-07 |
University of Florida |
Method of preparing recombinant adeno-associated virus compositions by using an iodixanol gradient
|
US6258603B1
(en)
|
1998-06-17 |
2001-07-10 |
Rohm And Haas Company |
Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
US6210892B1
(en)
|
1998-10-07 |
2001-04-03 |
Isis Pharmaceuticals, Inc. |
Alteration of cellular behavior by antisense modulation of mRNA processing
|
US6200560B1
(en)
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
US6221349B1
(en)
|
1998-10-20 |
2001-04-24 |
Avigen, Inc. |
Adeno-associated vectors for expression of factor VIII by target cells
|
US7109317B1
(en)
|
1998-11-06 |
2006-09-19 |
President And Fellows Of Harvard College |
FK506-based regulation of biological events
|
WO2000028004A1
(en)
|
1998-11-10 |
2000-05-18 |
The University Of North Carolina At Chapel Hill |
Virus vectors and methods of making and administering the same
|
ATE403715T1
(de)
|
1999-08-09 |
2008-08-15 |
Targeted Genetics Corp |
Erhöhung der expression einer einzelsträngigen, heterologen nukleotidsequenz von einem rekombinanten viralen vektor durch ausgestaltung der sequenz in einer art und weise, dass basenpaarungen innerhalb der sequenz entstehen
|
US7067526B1
(en)
|
1999-08-24 |
2006-06-27 |
Ariad Gene Therapeutics, Inc. |
28-epirapalogs
|
US6780639B1
(en)
|
1999-08-24 |
2004-08-24 |
Universite Libre De Bruxelles |
Antibiotic inducible/repressible genetic construct for gene therapy or gene immunization
|
EP1212331B1
(en)
|
1999-08-24 |
2004-04-21 |
Ariad Gene Therapeutics, Inc. |
28-epirapalogs
|
JP3961737B2
(ja)
|
2000-02-29 |
2007-08-22 |
株式会社小糸製作所 |
車両用灯具およびその製造方法
|
WO2001070816A2
(en)
|
2000-03-22 |
2001-09-27 |
Rohm And Haas Company |
Ecdysone receptor-based inducible gene expression system
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
US7201898B2
(en)
|
2000-06-01 |
2007-04-10 |
The University Of North Carolina At Chapel Hill |
Methods and compounds for controlled release of recombinant parvovirus vectors
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
WO2002066615A2
(en)
|
2001-02-20 |
2002-08-29 |
Rheogene, Inc. |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
CA2445796C
(en)
|
2001-02-20 |
2014-09-16 |
Rheogene, Inc. |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
JP4955904B2
(ja)
|
2001-02-20 |
2012-06-20 |
イントレキソン コーポレーション |
新規エクジソン受容体/無脊椎動物レチノイドx受容体−ベースの誘導性遺伝子発現システム
|
US7531326B2
(en)
|
2001-02-20 |
2009-05-12 |
Intrexon Corporation |
Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system
|
DE60227943D1
(de)
|
2001-05-18 |
2008-09-11 |
Wisconsin Alumni Res Found |
Verfahren zur synthese von dna-sequenzen die photolabile linker verwenden
|
PL220644B1
(pl)
|
2001-11-13 |
2015-11-30 |
Univ Pennsylvania |
Wirus stowarzyszony z adenowirusem (AAV), kompozycja, wyizolowane białko kapsydowe, wyizolowane lub syntetyczne cząsteczki kwasu nukleinowego, sposób wytwarzania zrekombinowanego wirusa, komórka gospodarza
|
ES2602352T3
(es)
|
2001-12-17 |
2017-02-20 |
The Trustees Of The University Of Pennsylvania |
Secuencias de serotipo 8 de virus adenoasociado (VAA), vectores que las contienen y usos de las mismas
|
US20070015238A1
(en)
|
2002-06-05 |
2007-01-18 |
Snyder Richard O |
Production of pseudotyped recombinant AAV virions
|
WO2005013090A2
(en)
|
2003-08-01 |
2005-02-10 |
Dna Twopointo Inc. |
Systems and methods for biopolymer engineering
|
US8005620B2
(en)
|
2003-08-01 |
2011-08-23 |
Dna Twopointo Inc. |
Systems and methods for biopolymer engineering
|
US7906111B2
(en)
|
2003-09-30 |
2011-03-15 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
|
US20060246079A1
(en)
|
2003-11-14 |
2006-11-02 |
Morrow Phillip R |
Neutralizing human antibodies to anthrax toxin
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
US7838657B2
(en)
|
2004-12-03 |
2010-11-23 |
University Of Massachusetts |
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences
|
EP4234687A2
(en)
|
2005-04-07 |
2023-08-30 |
The Trustees of the University of Pennsylvania |
Method of increasing the function of an aav vector
|
PT3520823T
(pt)
|
2005-05-02 |
2021-09-16 |
Genzyme Corp |
Terapia genética para distúrbios neurometabólicos
|
WO2006132118A1
(ja)
|
2005-06-09 |
2006-12-14 |
Matsushita Electric Industrial Co., Ltd. |
振幅誤差補償装置及び直交度誤差補償装置
|
EP3308788B1
(en)
|
2005-06-23 |
2018-10-24 |
Biogen MA Inc. |
Compositions and methods for modulation of smn2 splicing
|
US8877187B2
(en)
|
2005-07-25 |
2014-11-04 |
Avianax, Llc |
Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
|
EP2007795B1
(en)
|
2006-03-30 |
2016-11-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Aav capsid proteins
|
JP5268890B2
(ja)
|
2006-04-28 |
2013-08-21 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
Aavの規模適応性の製造方法
|
SI2029742T1
(sl)
|
2006-06-07 |
2016-11-30 |
Genzyme Corporation |
Genska terapija amiotrofične lateralne skleroze in drugih motenj hrbtenjače
|
WO2008042420A2
(en)
|
2006-10-03 |
2008-04-10 |
Genzyme Corporation |
Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
|
US20090075378A1
(en)
|
2007-02-20 |
2009-03-19 |
Anaptysbio, Inc. |
Somatic hypermutation systems
|
EP2125886A2
(en)
|
2007-03-13 |
2009-12-02 |
Humabs LLC |
Antibodies against h5n1 strains of influenza a virus
|
US9217020B2
(en)
|
2007-04-17 |
2015-12-22 |
National Research Council Of Canada |
Constructs for enhancement of gene expression in muscle
|
WO2008156763A2
(en)
|
2007-06-15 |
2008-12-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human neutralizing monoclonal antibodies to h5n1 influenza a virus
|
PT2220116E
(pt)
|
2007-11-12 |
2012-12-07 |
Theraclone Sciences Inc |
Composições e métodos para a terapia e o diagnóstico da gripe
|
WO2009079259A2
(en)
|
2007-12-06 |
2009-06-25 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against influenza virus and methods of use thereof
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
CN102046656A
(zh)
|
2008-03-28 |
2011-05-04 |
航道生物技术有限责任公司 |
针对病毒抗原的中和性分子
|
ITTO20080398A1
(it)
|
2008-05-27 |
2009-11-28 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
|
WO2010044921A2
(en)
|
2008-06-03 |
2010-04-22 |
Vaxin Inc. |
Intranasal administration of receptor-binding ligands or genes encoding such ligands as a therapeutic regimen for mitigating infections caused by respiratory pathogens
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
US9340603B2
(en)
|
2008-07-25 |
2016-05-17 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
MX353900B
(es)
|
2008-11-07 |
2018-02-01 |
Massachusetts Inst Technology |
Lipidoides de aminoalcohol y usos de los mismos.
|
US8211631B2
(en)
|
2008-12-18 |
2012-07-03 |
Wisconsin Alumni Research Foundation |
In vitro model of spinal muscular atrophy
|
CN107083400A
(zh)
*
|
2009-05-02 |
2017-08-22 |
建新公司 |
神经退行性疾病的基因治疗
|
MX2011011331A
(es)
|
2009-05-11 |
2011-11-18 |
Crucell Holland Bv |
Moleculas de union humanas capaces de neutralizar el virus de la influenza h3n2 y usos de las mismas.
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
IT1395961B1
(it)
|
2009-06-01 |
2012-11-02 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
|
KR20210057223A
(ko)
|
2009-06-17 |
2021-05-20 |
바이오젠 엠에이 인코포레이티드 |
대상에게서 smn2 스플라이싱을 조정하기 위한 조성물 및 방법
|
SG10201403557QA
(en)
|
2009-06-25 |
2014-10-30 |
Medimmune Llc |
Swine influenza hemagglutinin variants
|
US8598331B2
(en)
|
2009-09-28 |
2013-12-03 |
The University Of British Columbia |
CLDN5 mini-promoters
|
US9315825B2
(en)
|
2010-03-29 |
2016-04-19 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
SG10201502270TA
(en)
|
2010-03-29 |
2015-05-28 |
Univ Pennsylvania |
Pharmacologically induced transgene ablation system
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
JP6091435B2
(ja)
|
2011-02-22 |
2017-03-08 |
カリフォルニア インスティチュート オブ テクノロジー |
アデノ随伴ウイルス(aav)ベクターを用いたタンパク質の送達
|
EP3699286A1
(en)
|
2011-04-20 |
2020-08-26 |
The Trustees of the University of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
US20140127749A1
(en)
|
2011-04-21 |
2014-05-08 |
Arizona Borad Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizo |
Methods of protein production and compositions thereof
|
CN103906527B
(zh)
|
2011-06-08 |
2020-07-10 |
川斯勒佰尔公司 |
Mrna递送的脂质纳米颗粒组合物和方法
|
FR2977562B1
(fr)
|
2011-07-06 |
2016-12-23 |
Gaztransport Et Technigaz |
Cuve etanche et thermiquement isolante integree dans une structure porteuse
|
DK2731967T3
(en)
|
2011-07-14 |
2017-01-16 |
Janssen Vaccines & Prevention Bv |
HUMAN BINDING MOLECULES CAPABLE OF NEUTRALIZING INFLUENZA A VIRUS FROM PHYLOGENETIC GROUP 1 AND PHYLOGENETIC GROUP 2 AND INFLUENZA B VIRUS
|
WO2013114885A1
(en)
|
2012-01-31 |
2013-08-08 |
Osaka University |
Human monoclonal antibodies broadly protective against influenza b virus and methods of using the same
|
CN108640989B
(zh)
|
2012-03-08 |
2021-12-14 |
扬森疫苗与预防公司 |
可结合并中和b型流感病毒的人类结合分子及其用途
|
EP2834259A4
(en)
*
|
2012-04-02 |
2016-08-24 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES
|
WO2013155222A2
(en)
|
2012-04-10 |
2013-10-17 |
The Regents Of The University Of California |
Brain-specific enhancers for cell-based therapy
|
CN104487579B
(zh)
|
2012-04-18 |
2022-01-18 |
费城儿童医院 |
使用aav衣壳变异体的高度有效的基因转移的组合物和方法
|
CA2873274C
(en)
|
2012-06-08 |
2021-06-01 |
Ethris Gmbh |
Pulmonary delivery of messenger rna
|
CN104704123A
(zh)
|
2012-06-21 |
2015-06-10 |
肌肉学研究协会 |
基因治疗载体的广泛的基因递送
|
RS60318B1
(sr)
|
2012-08-01 |
2020-07-31 |
Ikaika Therapeutics Llc |
Ublažavanje tkivnog oštećenja i fibroze pomoću anti-ltbp4 antitela
|
US9719106B2
(en)
|
2013-04-29 |
2017-08-01 |
The Trustees Of The University Of Pennsylvania |
Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
|
BR112015027336A2
(pt)
*
|
2013-05-01 |
2017-09-26 |
Genzyme Corp |
composições e processos para tratamento de atrofia muscular espinhal
|
BR112016001592A2
(pt)
|
2013-07-26 |
2017-11-28 |
Univ Iowa Res Found |
métodos e composições para o tratamento de doenças cerebrais
|
US20150110857A1
(en)
*
|
2013-10-22 |
2015-04-23 |
Shire Human Genetic Therapies, Inc. |
Cns delivery of mrna and uses thereof
|
JP6873699B2
(ja)
|
2013-10-24 |
2021-05-19 |
ユニキュアー アイピー ビー.ブイ. |
Aav5カプシドタンパク質を含むアデノ随伴ウイルス(aav)を用いた神経学的疾患の処置
|
SG11201606047RA
(en)
|
2014-02-19 |
2016-09-29 |
Jody Berry |
Ebola monoclonal antibodies
|
US10746742B2
(en)
*
|
2014-04-25 |
2020-08-18 |
Oregon Health & Science University |
Methods of viral neutralizing antibody epitope mapping
|
ES2876409T3
(es)
|
2014-04-25 |
2021-11-12 |
Univ Pennsylvania |
Variantes del RLBD y su uso en composiciones para reducir los niveles de colesterol
|
WO2015164723A1
(en)
|
2014-04-25 |
2015-10-29 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for treating metastatic breast cancer and other cancers in the brain
|
US10982228B2
(en)
|
2014-05-02 |
2021-04-20 |
Genzyme Corporation |
AAV vectors for retinal and CNS gene therapy
|
PT3142750T
(pt)
|
2014-05-13 |
2020-09-22 |
Univ Pennsylvania |
Composições que compreendem aav expressando construções de anticorpos duplos e suas utilizações
|
KR20230067694A
(ko)
|
2014-09-24 |
2023-05-16 |
시티 오브 호프 |
고효율 게놈 편집을 위한 아데노-관련 바이러스 벡터 변이체 및 이의 방법
|
EP3201226A2
(en)
|
2014-10-03 |
2017-08-09 |
Massachusetts Institute of Technology |
Antibodies that bind ebola glycoprotein and uses thereof
|
US10370435B2
(en)
|
2015-02-05 |
2019-08-06 |
Janssen Vaccines & Prevention B.V. |
Binding molecules directed against influenza hemagglutinin and uses thereof
|
US11535665B2
(en)
|
2015-05-13 |
2022-12-27 |
The Trustees Of The University Of Pennsylvania |
AAV-mediated expression of anti-influenza antibodies and methods of use thereof
|
US11135313B2
(en)
|
2015-10-28 |
2021-10-05 |
The Trustees Of The University Of Pennsylvania |
Intrathecal administration of adeno-associated-viral vectors for gene therapy
|
EP3387118B1
(en)
|
2015-12-11 |
2022-04-06 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aavrh10
|
US11015173B2
(en)
|
2015-12-11 |
2021-05-25 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAV1
|
WO2017100676A1
(en)
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav8
|
EP3387138B1
(en)
|
2015-12-11 |
2022-01-26 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav9
|
WO2017106326A1
(en)
|
2015-12-14 |
2017-06-22 |
The Trustees Of The University Of Pennsylvania |
Aav-anti pcsk9 antibody constructs and uses thereof
|
WO2017106354A1
(en)
|
2015-12-14 |
2017-06-22 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated viral vectors useful in treatment of spinal muscular atropy
|
WO2017106244A1
(en)
|
2015-12-14 |
2017-06-22 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for regulatable antibody expression
|
MA43968A
(fr)
|
2016-02-03 |
2018-12-12 |
Univ Pennsylvania |
Thérapie génique pour traiter la mucopolysaccharidose de type i
|
JP7021191B2
(ja)
|
2016-08-15 |
2022-02-16 |
ジェンザイム・コーポレーション |
Aavを検出するための方法
|
WO2018057916A1
(en)
|
2016-09-24 |
2018-03-29 |
The Trustees Of The University Of Pennsylvania |
Novel humanized anti-ebola antibodies useful in preventing ebola infections
|
KR20190135000A
(ko)
|
2017-02-28 |
2019-12-05 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Aav 벡터를 기반으로 하는 인플루엔자 백신
|
SI3589730T1
(sl)
|
2017-02-28 |
2024-04-30 |
The Trustees Of The University Of Pennsylvania |
Adeno-povezan virus (AAV) clade F vektor in njihova uporaba
|